BFC Planning’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
BFC Planning's BMRN Position: Q3 2026 in Review
BFC Planning held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2026 at 145 shares worth $8.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2461.
BFC Planning first reported a position in BMRN in Q2 2025 and has held it in 6 quarters since. 443 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- BFC Planning held 145 shares of BioMarin Pharmaceuticals worth $8.7K as of Q3 2026.
- BFC Planning left its BioMarin Pharmaceuticals share count unchanged in Q3 2026.
- BioMarin Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2461 holding.
- BFC Planning first reported a position in BioMarin Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
- 443 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.